New Products In Brief
This article was originally published in The Gray Sheet
Recent launches and approvals include overseas debuts of Abbott’s Absorb bioabsorbable vascular scaffold and Medtronic’s next-generation CoreValve Evolut transcatheter aortic heart valve.
You may also be interested in...
Latest clinical results for Abbott’s Absorb Bioresorbable Vascular Scaffold show the disappearing stent actually increases the space inside the stented vessel segment over time. The company’s efforts to launch a pivotal randomized trial of the device are hindered by FDA, according to the lead investigator.
The ATSM technical contact on the newly released international standard on pre-clinical characterizations for absorbable devices discusses the development of the standard and its impact on industry.
Oslo breast cancer detection study is good news for Hologic. Abbott's bioresorbable stent trial gets under way. More research briefs.